|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-2-4
|
|
pubmed:abstractText |
Dyslipidemia frequently complicates chronic nephropathies and increases the risk of renal and cardiovascular events. This might be ameliorated by drugs, such as angiotensin-converting enzyme inhibitors, which effectively reduce proteinuria.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Diuretics,
http://linkedlifedata.com/resource/pubmed/chemical/Lisinopril,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium, Dietary,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
4
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
586-92
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12566371-Adolescent,
pubmed-meshheading:12566371-Adult,
pubmed-meshheading:12566371-Aged,
pubmed-meshheading:12566371-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:12566371-Antihypertensive Agents,
pubmed-meshheading:12566371-Cholesterol,
pubmed-meshheading:12566371-Cholesterol, HDL,
pubmed-meshheading:12566371-Cholesterol, LDL,
pubmed-meshheading:12566371-Chronic Disease,
pubmed-meshheading:12566371-Diuretics,
pubmed-meshheading:12566371-Dose-Response Relationship, Drug,
pubmed-meshheading:12566371-Female,
pubmed-meshheading:12566371-Hemodynamics,
pubmed-meshheading:12566371-Humans,
pubmed-meshheading:12566371-Hypercholesterolemia,
pubmed-meshheading:12566371-Hypoalbuminemia,
pubmed-meshheading:12566371-Hypotension,
pubmed-meshheading:12566371-Kidney Diseases,
pubmed-meshheading:12566371-Kidney Function Tests,
pubmed-meshheading:12566371-Lisinopril,
pubmed-meshheading:12566371-Longitudinal Studies,
pubmed-meshheading:12566371-Male,
pubmed-meshheading:12566371-Maximum Tolerated Dose,
pubmed-meshheading:12566371-Middle Aged,
pubmed-meshheading:12566371-Proteinuria,
pubmed-meshheading:12566371-Sodium, Dietary,
pubmed-meshheading:12566371-Treatment Outcome,
pubmed-meshheading:12566371-Triglycerides
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies.
|
|
pubmed:affiliation |
Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Mario Negri Institute, Bergamo, Italy. manuelap@marionegri.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
